P.1 Management of gestational diabetes in maternal phenylketonuria von Arduini, K, Vucko, E, Burton, B

Volltext

Development of an overdue outreach program to improve adherence to PKU management von Arduini, K, Vucko, E, Havens, K, Bausell, H, Bueno, A, Kozek, A, Paras, A, Shim, S

Volltext

P.29 - Development of an overdue outreach program to improve adherence to PKU management von Arduini, K, Vucko, E, Havens, K, Bausell, H, Bueno, A, Kozek, A, Paras, A, Shim, S

Volltext

Pegvaliase therapy in sapropterin-responsive PKU patients von Vucko, ER, Havens, KE, Baker, JJ, Arduini, KJ, Bausell, HA, Kozek, AC, Bueno, A, Paras, AL

Volltext

P.44 - Pegvaliase therapy in sapropterin-responsive PKU patients von Vucko, ER, Havens, KE, Baker, JJ, Arduini, KJ, Bausell, HA, Kozek, AC, Bueno, A, Paras, AL

Volltext

Pegvaliase dose escalation to 80 mg daily may lead to efficacy in patients who do not exhibit an optimal response at lower doses von Vucko, Erika R., Havens, Kirsten E., Baker, Joshua J., Burton, Barbara K.

Volltext

Treatment-naive and post-treatment glucosylsphingosine (lyso-GL1) levels in a cohort of pediatric patients with Gaucher disease von Rasmussen, Carly A., Quadri, Allegra, Vucko, Erika, Kim, Katherine, Hickey, Rachel, Baker, Joshua J., Charrow, Joel, Prada, Carlos E.

Volltext

Lessons learned from 5 years of pegvaliase in US clinics: A case series von Cooney, Erin, Ammous, Zineb, Bender, Tricia, Clague, Gillian E., Clifford, Marilyn, Crutcher, Angela, Davis-Keppen, Laura, Havens, Kirsten, Lah, Melissa, Sacharow, Stephanie, Sanchez-Valle, Amarilis, Vucko, Erika, Wardley, Bridget, Wessenberg, Leah, Andersson, Hans C.

Volltext

Efficacy and safety of empagliflozin in glycogen storage disease type Ib: Data from an international questionnaire von Grünert, Sarah C., Derks, Terry G.J., Adrian, Katarina, Al-Thihli, Khalid, Ballhausen, Diana, Bidiuk, Joanna, Bordugo, Andrea, Boyer, Monica, Bratkovic, Drago, Brunner-Krainz, Michaela, Burlina, Alberto, Chakrapani, Anupam, Corpeleijn, Willemijn, Cozens, Alison, Dawson, Charlotte, Dhamko, Helena, Milosevic, Maja Djordjevic, Eiroa, Hernan, Finezilber, Yael, Moura de Souza, Carolina Fischinger, Garcia-Jiménez, Maria Concepción, Gasperini, Serena, Haas, Dorothea, Häberle, Johannes, Halligan, Rebecca, Fung, Law Hiu, Hörbe-Blindt, Alexandra, Horka, Laura Maria, Huemer, Martina, Uçar, Sema Kalkan, Kecman, Bozica, Kilavuz, Sebile, Kriván, Gergely, Lindner, Martin, Lüsebrink, Natalia, Makrilakis, Konstantinos, Mei-Kwun Kwok, Anne, Maier, Esther M., Maiorana, Arianna, McCandless, Shawn E., Mitchell, John James, Mizumoto, Hiroshi, Mundy, Helen, Ochoa, Carlos, Pierce, Kathryn, Fraile, Pilar Quijada, Regier, Debra, Rossi, Alessandro, Santer, René, Schuman, Hester C., Sobieraj, Piotr, Spenger, Johannes, Spiegel, Ronen, Stepien, Karolina M., Tal, Galit, Tanšek, Mojca Zerjav, Torkar, Ana Drole, Tchan, Michel, Thyagu, Santhosh, Schrier Vergano, Samantha A., Vucko, Erika, Weinhold, Natalie, Zsidegh, Petra, Wortmann, Saskia B.

Volltext

Anodic degradation of Zn-Ni coatings in moderately alkaline NaC1 solution von Vucko, F., Prestat, M., Holzer, L., Tribollet, Bernard E, Pélissier, K., Thierry, D.

Volltext

Pegvaliase dose escalation to 80 mg daily may lead to efficacy in patients who do not exhibit an optimal response at lower doses von Vucko, Erika R, Havens, Kirsten E, Baker, Joshua J, Burton, Barbara K

Volltext

Simulation within the railroad environment von Krueger, H., Vaillancourt, E., Drummie, A.M., Vucko, S.J., Bekavac, J.

Volltext bestellen